Investigation of Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) Porphyrazine for Cancer Treatment
Author Information
Author(s): Sakamoto Keiichi, Ohno-Okumura Eiko, Kato Taku, Watanabe Masaki, Cook Michael J.
Primary Institution: Nihon University
Hypothesis
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine is expected to be an effective photosensitizer for photodynamic therapy of cancer.
Conclusion
The study found that the light-exposed DMS quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines caused cell disruption in cancer cells.
Supporting Evidence
- The synthesized compound showed amphiphilic properties after quaternization.
- Fluorescence microscopy revealed cell disruption after light exposure.
- The compound was synthesized with an 80% yield.
- Quaternization improved the solubility of the compound in water.
- Electrochemical characterization indicated increased electron responsibility after quaternization.
Takeaway
The researchers made a new chemical that helps treat cancer by using light to damage cancer cells.
Methodology
The compound was synthesized and tested for its effectiveness in photodynamic therapy using cancer cell cultures.
Limitations
The study did not isolate the regio isomers of the synthesized compound.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website